By clicking “View Open Positions”, you acknowledge and consent to your personal information being transferred cross-border to Pivotal Headquarters in Hong Kong. For more details, please refer to the Recruitment Privacy Policy.
Vaxcyte
THERAPEUTIC AREA
Vaccines
YEAR INVESTED
2017
STAGE
Public
WEBSITE
Vaxcyte is a vaccine innovation company developing broad-spectrum conjugate and novel protein vaccines to protect humankind from bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum, carrier-sparing pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease.
SHANGHAI
Suite 2001, YI FUNG PLACE
99 West Ziyun Road
Changning District
Shanghai 200051, China
HONG KONG
17th Floor
AIRSIDE
2 Concorde Road, Kai Tak
Hong Kong SAR
SAN FRANCISCO
501 2nd Street, Suite 200
San Francisco, CA 94107
United States
中文
English
